The efficiency and safety of oxygen-supplemented accelerated transepithelial corneal cross-linking.
Emre AydınMehmet Gökhan AslanPublished in: International ophthalmology (2021)
Keratoconus progression was significantly halted in both groups 12 months after the treatment. In addition, oxygen supplementation during A-TE CXL further significantly increased clinical outcomes compared to room air conditions without any significant change in ECD measures.